Opus Genetics (IRD) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -41.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.51% |
| Dec 31, 2025 | -32.20% |
| Sep 30, 2025 | -20.02% |
| Jun 30, 2025 | -40.83% |
| Mar 31, 2025 | -57.35% |
| Dec 31, 2024 | -263.54% |
| Sep 30, 2024 | -70.83% |
| Jun 30, 2024 | -837.31% |
| Mar 31, 2024 | -56.77% |
| Dec 31, 2023 | -84.20% |
| Sep 30, 2023 | 33.24% |
| Jun 30, 2023 | 125.96% |
| Mar 31, 2023 | 40.91% |
| Dec 31, 2022 | 609.94% |
| Sep 30, 2022 | -25.50% |
| Jun 30, 2022 | 11.99% |
| Mar 31, 2022 | -6.16% |
| Dec 31, 2021 | -29.55% |
| Sep 30, 2021 | -239.39% |
| Jun 30, 2021 | -564.82% |
| Mar 31, 2021 | -693.99% |
| Dec 31, 2020 | -187.76% |
| Sep 30, 2020 | 55.59% |
| Jun 30, 2020 | 64.09% |
| Mar 31, 2020 | 83.34% |
| Dec 31, 2019 | 207.48% |
| Sep 30, 2019 | 43.42% |
| Jun 30, 2019 | 59.30% |
| Mar 31, 2019 | 21.56% |
| Dec 31, 2018 | -22.92% |
| Sep 30, 2018 | -21.80% |
| Jun 30, 2018 | -8.29% |
| Mar 31, 2018 | -34.23% |
| Dec 31, 2017 | -151.63% |
| Sep 30, 2017 | -10.52% |
| Jun 30, 2017 | 18.80% |
| Mar 31, 2017 | -17.40% |
| Dec 31, 2016 | 66.19% |
| Sep 30, 2016 | 31.27% |
| Jun 30, 2016 | -14.94% |
| Mar 31, 2016 | 12.17% |
| Dec 31, 2015 | -51.14% |
| Sep 30, 2015 | -73.54% |
| Jun 30, 2015 | -48.82% |
| Mar 31, 2015 | -56.83% |
| Dec 31, 2014 | -29.76% |
| Sep 30, 2014 | -51.69% |
| Jun 30, 2014 | -18.24% |
| Mar 31, 2014 | -66.25% |
| Dec 31, 2013 | -109.84% |
| Sep 30, 2013 | -4.60% |
| Jun 30, 2013 | -26.51% |
| Mar 31, 2013 | 19.01% |
| Dec 31, 2012 | 78.05% |
| Sep 30, 2012 | 47.85% |
| Jun 30, 2012 | 60.93% |
| Mar 31, 2012 | 21.00% |
| Dec 31, 2011 | -101.97% |
| Sep 30, 2011 | -98.95% |